The present study have found that serum ferroptosis markers GPX4 and ACSL4 as well as iron metabolism indexes are closely related to the severity of renal disease in type 2 diabetic patients, which may become biomarkers for diagnosis and treatment monitoring of diabetic nephropathy in the future. The gene discussed is ACSL4; the disease is type 2 diabetes mellitus.